Lundbeckfonden BioCapital

🏷️ vc
Website besuchen ↗
Investitionsthese

Lundbeckfonden is an enterprise foundation with a dual mission: to grant funds for biomedical sciences research, particularly neuroscience, and to actively invest in healthcare businesses. Their strategy, "Bringing Discoveries to Lives," aims to double grants for research in Denmark and develop a clearer focus on the brain. They strive to improve interaction between universities, hospitals, and businesses by investing in talented researchers, entrepreneurs, and innovation. The foundation develops healthcare businesses and helps them become global leaders by taking on the role of a competent and engaged owner, while generating attractive financial returns to fund their increasing grant portfolio and ensure long-term economic robustness and growth. They also aim to become an active voice in public debate, contributing to the development and internationalisation of Danish health research and business culture, and broadening society’s understanding of the brain and its diseases. Lundbeckfonden's investment strategy emphasizes long-term value creation. They focus on strategic ownerships in established healthcare companies and investments in biotech companies. The foundation seeks to improve lives and steer society in a healthier direction, with an ambition for Denmark to become a leading research nation in healthcare. They aim to fund research that promotes a better understanding of the brain and better prevention, diagnosis, and treatment of brain disorders. The foundation's commitment to social responsibility is reflected in their activities as an owner, investor, and grant-maker. They are committed to transparency and adhere to high standards of governance. They report to the UN Global Compact on their activities to comply with and raise awareness of responsible business principles. The Lundbeck Foundation also implements a whistleblower scheme to promote transparency and accountability in their operations. Their strategy is guided by the principle of creating powerful ripple effects that bring discoveries to lives. This means investing actively in business and science at the frontiers of their fields, fostering innovation and driving breakthroughs for the benefit of society. They prioritize collaboration between research and business, aiming to translate scientific discoveries into innovative healthcare solutions and new healthcare companies in Denmark.

Investitionsphase
Not explicitly mentioned, but includes investments in both established and early-stage biotech companies.

Bevorzugte Reifephase für die erste Finanzierung.

Sektoren & Themen

Biotech, Healthcare, Neuroscience, Biomedical Sciences

Thematische Schwerpunkte und Zielmarktsegmente von Interesse.

Ticketgröße
k.A. - €35.000.000

Standard-Finanzierungsbetrag pro Runde.

Outreach & Dossier-Analysen

Verifiziertes E-Mail-Muster

[email protected] | [email protected]

Analysen-Scorecard der Investitionsthese

Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...

Verifizierte Partnerkontakte freischalten

Finde verifizierte E-Mail-Vorlagen, direkt von der KI verfasste Outreach-Texte und berechne Übereinstimmungen mit 1 Klick.

Kostenloses Konto erstellen

Dauert weniger als 30 Sekunden · Keine Kreditkarte erforderlich